Flutamide (Compound)
Synonyms:flutamide, 13311-84-7, Eulexin, Niftolide, Niftholide, Sch 13521, 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide, NFBA, niftolid, Drogenil, Flutamin, Cebatrol, veterinary, Flutamida, Flutamidum, Sch-13521, 4'-Nitro-3'-trifluoromethylisobutyranilide, 2-Methyl-N-(4-nitro-3-[trifluoromethyl]phenyl)propanamide, N-(4-NITRO-3-(TRIFLUOROMETHYL)PHENYL)ISOBUTYRAMIDE, SCH13521, MFCD00072009, NSC 215876, alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide, CHEMBL806, Propanamide, 2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-, Propanamide, 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-, NSC-215876, 4-Nitro-3-(trifluoromethyl)isobutyranilide, CHEBI:5132, DTXSID7032004, 76W6J0943E, NCGC00015452-09, Eulexine, Chimax, 4'-Nitro-3'-trifluoromethylisobutyramilide, CAS-13311-84-7, Ham's F-12 medium, Flutamidum [INN-Latin], Flutamida [INN-Spanish], Flutamide USP25, N-[4-Nitro-3-(trifluoromethyl)phenyl]isobutyramide, DTXCID9011121, Prostandril, Odyne, .alpha.,.alpha.,.alpha.-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide, SMR000058187, Eulexin (TN), CCRIS 7246, m-Propionotoluidide,.alpha.,.alpha.-trifluoro-, SR-01000075888, EINECS 236-341-9, BRN 2157663, .alpha.,.alpha.-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide, m-Propionotoluidide,.alpha.,.alpha.-trifluoro-2-methyl-4'-nitro-, UNII-76W6J0943E, 4'-Nitro-3'-(trifluoromethyl)isobutyranilide, Flutamide [USAN:USP:INN:BAN], Flutamide,(S), Prestwick_228, Flutamide (Eulexin), NK-601, Spectrum_001210, 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propionamide, CPD000058187, FLUTAMIDE [INN], FLUTAMIDE [JAN], FLUTAMIDE [MI], FLUTAMIDE [USAN], Prestwick0_000180, Prestwick1_000180, Prestwick2_000180, Prestwick3_000180, Spectrum2_001201, Spectrum3_001421, Spectrum4_000829, Spectrum5_001450, Lopac-F-9397, F0663, Flutamide (pubertal study), FLUTAMIDE [MART.], F 9397, FLUTAMIDE [USP-RS], FLUTAMIDE [WHO-DD], SCHEMBL3934, Lopac0_000557, BSPBio_000079, BSPBio_003122, KBioGR_001377, KBioSS_001690, MLS000069634, MLS001065596, MLS002548892, DivK1c_000459, SPECTRUM1500995, SPBio_000982, SPBio_002000, Flutamide (JP17/USP/INN), BPBio1_000087, GTPL6943, FLUTAMIDE [EP IMPURITY], FLUTAMIDE [ORANGE BOOK], CHEMBL4759307, FLUTAMIDE [EP MONOGRAPH], SCHEMBL12932289, HMS501G21, KBio1_000459, KBio2_001690, KBio2_004258, KBio2_006826, KBio3_002342, FLUTAMIDE [USP MONOGRAPH], NINDS_000459, HMS1568D21, HMS1921O16, HMS2090I18, HMS2092O14, HMS2095D21, HMS2230P19, HMS3259I03, HMS3261P15, HMS3373C12, HMS3655G22, HMS3712D21, Pharmakon1600-01500995, AMY32524, BCP23006, HY-B0022, Tox21_110154, Tox21_202169, Tox21_300536, Tox21_500557, BDBM50131270, CCG-39105, m-Propionotoluidide, 2-methyl-4'-nitro-alpha,alpha,alpha-triflouro-, m-Propionotoluidide, alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro-, NSC147834, NSC215876, NSC757817, s1908, AKOS001025465, AKOS025243203, m-Propionotoluidide, .alpha.,.alpha.,.alpha.-trifluoro-2-methyl-4'-nitro-, Tox21_110154_1, AB02835, DB00499, KS-5091, LP00557, NC00451, NSC-147834, NSC-757817, SDCCGSBI-0050540.P004, IDI1_000459, NCGC00015452-01, NCGC00015452-02, NCGC00015452-03, NCGC00015452-04, NCGC00015452-05, NCGC00015452-06, NCGC00015452-07, NCGC00015452-08, NCGC00015452-10, NCGC00015452-11, NCGC00015452-12, NCGC00015452-13, NCGC00015452-14, NCGC00015452-15, NCGC00015452-16, NCGC00015452-19, NCGC00015452-20, NCGC00015452-32, NCGC00091460-01, NCGC00091460-02, NCGC00091460-03, NCGC00091460-04, NCGC00091460-05, NCGC00091460-06, NCGC00091460-07, NCGC00091460-08, NCGC00091460-09, NCGC00254495-01, NCGC00259718-01, NCGC00261242-01, AC-24192, BF166239, SY036411, SBI-0050540.P003, DB-042163, 3'-Trifluoromethyl-4'-Nitro-Isobutyranilide, AB00052188, EU-0100557, FT-0626493, FT-0668764, SW196536-4, 4''-nitro-3''-trifluoromethylisobutyranilide, C07653, D00586, EN300-119548, AB00052188-09, AB00052188_10, AB00052188_11, A806562, Q418669, Q-201131, SR-01000075888-1, SR-01000075888-6, SR-01000075888-7, SR-01000075888-9, BRD-K28307902-001-05-0, Flutamide, certified reference material, TraceCERT(R), Z56755651, a,a,a-Trifluoro-2-methyl-4'-nitro- m-propionotoluidide, Flutamide, European Pharmacopoeia (EP) Reference Standard, 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide #, Flutamide, United States Pharmacopeia (USP) Reference Standard, 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide;Flutamide, alpha,alpha,alpha-trifluoro-2-methyl-4''-nitro-m-propionotoluidide, m-Propionotoluidide, 2-methyl-4'-nitro-.alpha.,.alpha.,.alpha.-trifluoro-, Flutamide for system suitability, European Pharmacopoeia (EP) Reference Standard, 37209-54-4
Id:3397
Description:nan
Analyze
CFDE DD-Knowledge Graph
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Flutamide's neighborhood in the knowledge graph.
GDLPA Landing Pages Links
The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Flutamide.
Playbook Workflow Builder
The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Flutamide.
Results found
Linked to
| Label | Description |
|
|---|---|---|---|
 | A Substance | ||
 | Metadatata for flutamide | ||
| DrugPage Collection: (DrugCentralID:01223; PubChem_CID:3397, FILE=drugcentral_drug_01223.json) |
Metadatata for flutamide
DrugPage Collection: (DrugCentralID:01223; PubChem_CID:3397, FILE=drugcentral_drug_01223.json)
DISPLAY PER PAGE
10
@CFDE Workbench 2025
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
@CFDE Workbench 2025